Full data view for gene MYL2

Information The variants shown are described using the NM_000432.3 transcript reference sequence.

3 entries on 1 page. Showing entries 1 - 3.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

Allele     

Type     

DNA change (genomic) (hg19)     

Reference     

DB-ID     

Frequency     

Variant remarks     

ClassClinical     

Template     

Technique     

Disease     

Reference     

Remarks     

Gender     

Age     

α-thal genotype     

β-thal genotype     

Panel size     

Owner     
./. 02 c.64G>A - p.Glu22Lys Unknown BL21 expression host cells; Sf9 cells - GenBank MYL2_00006 - The KCa value for E22K was decreased be ~17-fold compared with the wild-type light chain. Was Associated with a particular subtype of cardiac hypertrophy defined by mid-left ventricular obstruction. The phosphorylation of the FHC mutants affected their Ca2+ binding properties and prevented the E22K mutant from becoming phosphorylated. The nonphosphorylated E22K migrates slower than the nonphosphorylated wild-type HCRLC. E22K mutation results in an increase in the alpha-helical content of HCRLC from 18% to 24%. - - - - - - - - - - - -
./. 02 c.64G>A - p.Glu22Lys Unknown Blood - GenBank MYL2_00006 - This base change caused a loss of one of two normal Taq I restriction sites in the exon 2 amplimer allowing its independent confirmation by restriction enzyme digestion. - - - - - - - - - - - -
./. 02 c.64G>A - p.Glu22Lys Unknown BL21 expression host cells - GenBank MYL2_00006 - Affect the Ca2+ ability, the Ca2+sensitivity of ATPase activity and recovered force. - - - - - - - - - - - -
Legend   How to query